Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Urinary Tert Promoter Mutations Are Detectable up to 10 Years Prior to Clinical Diagnosis of Bladder Cancer: Evidence From the Golestan Cohort Study
Mohsen Ayati Efin
Mohsen Ayati Efin

Associate Professor of Urology

Department Urology

School of Medicine

Imam Khomeini Hospital Complex

Uro-Oncology Research Center

Tehran University of Medical Sciences

All Documents
1. A Rare Case of Non-Functional Paraganglioma of Urinary Bladder With No Luts, Urology Case Reports (2025)
2. Relationship Between Sarcopenia and Postoperative Complications in Bladder Cancer Patients Undergoing Radical Cystectomy; [بررسی ارتباط سارکوپنی با عوارض پس از جراحی در بیماران مبتلابه سرطان مثانه که تحت جراحی رادیکال سیستکتومی قرار گرفتهاند], Tehran University Medical Journal (2024)
3. Renal Synovial Sarcoma: Considerations for Radical Nephrectomy- a Case Report and Literature Review, Urology Case Reports (2024)
4. A Case Report of a Self-Inserted Foreign Body in the Urethra/Bladder Causing Urinary Calculus Formation, and a Review of the Literature, Heliyon (2023)
5. A Case Report of a Self-Inserted Foreign Body in the Urethra/Bladder Causing Urinary Calculus Formation, and a Review of the Literature, Heliyon (2023)
6. A Rare Case Report of Muscular Metastasis of Prostate Cancer, Urology Case Reports (2023)
7. Assessment of Tolerability, Response and Complications of Concurrent Chemoradiation With Capecitabine and Cisplatin in Muscle-Invasive Bladder Cancer; a Single Arm Study, Clinical Genitourinary Cancer (2023)
8. Log Odds of Positive Lymph Nodes (Lodds) As an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging, Clinical Genitourinary Cancer (2023)
9. National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period, International Journal of Cancer Management (2023)
10. The Effect of Melatonin on Improving the Benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial, Urology Journal (2022)
11. The Effect of Melatonin on Improving the Benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial, Urology Journal (2022)
12. Management of Primary Ewing Sarcoma of the Kidney With Inferior Vena Cava (Ivc) Tumor Thrombosis, Urology Case Reports (2021)
13. Primary Squamous Cell Carcinoma of Renal Parenchyma: Case Report and Review of Literature, Urology Case Reports (2021)
14. Renal Ewing's Sarcoma With the Spread of Tumor Thrombosis to the Inferior Vena Cava: Case Report, Tehran University Medical Journal (2021)
15. A Preliminary Study of Ner and Mmr Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on Progression-Free Survival, Iranian Journal of Pharmaceutical Research (2020)
16. Financial Burden of Prostate Cancer Screening: Changing Trends After Health Sector Reform in a Developing Country, Urology Journal (2020)
17. Investigation of the Relationship Between Prostate Specific Antigen Doubling Time and the Severity of a Malignant Tumor of the Prostate, Tehran University Medical Journal (2020)
18. Potential Prognostic Role for Spop, Daxx, Rarres1, and Lamp2 As an Autophagy Related Genes in Prostate Cancer, Urology Journal (2020)
19. Rate of Urinary Tract Infection After Urodynamic Study in Pelvic Floor Clinic, Caspian Journal of Internal Medicine (2020)
20. Rate of Urinary Tract Infection After Urodynamic Study in Pelvic Floor Clinic, Caspian Journal of Internal Medicine (2020)
21. Role of Chronic Inflammation As a Predictor of Upstaging/Upgrading in Prostate Cancer: Finding a New Group Eligible for Active Surveillance, Urology Journal (2020)
22. Serum and Urine Levels of Vascular Endothelial Growth Factor As Prognostic Markers in Patients With Bladder Cancer, Middle East Journal of Cancer (2020)
23. While Urine and Plasma Decorin Remain Unchanged in Prostate Cancer, Prostatic Tissue Decorin Has a Prognostic Value, Iranian Biomedical Journal (2020)
24. A Review on the Role of M2 Macrophages in Bladder Cancer; Pathophysiology and Targeting, International Immunopharmacology (2019)
25. Cancer-Testis Antigens As New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder, Pathology and Oncology Research (2019)
26. Economic Burden of Prostate Cancer in Iran: Measuring Costs and Quality of Life, Middle East Journal of Cancer (2019)
27. Effects of Opium Dependency on Testicular Tissue in a Rat Model: An Experimental Study, Urology Journal (2019)
28. Global, Regional and National Burden of Testicular Cancer, 1990–2016: Results From the Global Burden of Disease Study 2016, BJU International (2019)
29. Radical Cystectomy for Management of Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Rare Case Report, Urology Case Reports (2019)
30. Second Transurethral Resection of Bladder Tumor: Is It Necessary in All T1 And/Or High-Grade Tumors?, Urology Journal (2019)
31. Simultaneous Cesarean Section and Radical Nephrectomy With Tumor Thrombectomy During Pregnancy, Acta Medica Iranica (2019)
32. A Potential Clinical Significance of Dab2ip and Spry2 Transcript Variants in Prostate Cancer, Pathology Research and Practice (2018)
33. Odf4, Magea3, and Mageb4: Potential Biomarkers in Patients With Transitional Cell Carcinoma, Iranian Biomedical Journal (2018)
34. Dysregulated Expression of Long Intergenic Non-Coding Rnas (Lincrnas) in Urothelial Bladder Carcinoma, International Journal of Molecular and Cellular Medicine (2017)
35. Management of Hepatic Granulomatous Tuberculosis After Bcg Therapy for Bladder Cancer, Urology Case Reports (2017)
36. Degarelix for the Treatment of Advanced Prostate Cancer Compared With Gnrh-Agonists: A Systematic Review and Meta-Analysis, Medical Journal of the Islamic Republic of Iran (2016)
37. Development, Validation and Comparison of Two Nomograms Predicting Prostate Cancer at Initial 12-Core Biopsy, Asia-Pacific Journal of Clinical Oncology (2016)
38. Genetic Analysis of Iranian Autosomal Dominant Polycystic Kidney Disease: New Insight to Haplotype Analysis, Cellular and Molecular Biology (2016)
39. Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?, Nephro-Urology Monthly (2016)
40. Is There a Role for Urodynamic Study in Women With Urinary Incontinence?, Urology Journal (2016)
41. Pkd2 Mutation in an Iranian Autosomal Dominant Polycystic Kidney Disease Family With Misleading Linkage Analysis Data, Kidney Research and Clinical Practice (2016)
42. Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients With Clinically Localized Prostate Cancer, Nephro-Urology Monthly (2016)
43. Relationship Between Perineural Invasion in Prostate Needle Biopsy Specimens and Pathologic Staging After Radical Prostatectomy, Nephro-Urology Monthly (2016)
44. Adrenocortical Carcinoma With Renal Vein Thrombus Extended to Inferior Vena Cava: A Case Report, International Surgery (2015)
45. Age-Specific Reference Ranges of Serum Prostate-Specific Antigen in Iranian Men, Tehran University Medical Journal (2015)
46. Applying Extender Devices in Patients With Penile Dysmorphophobia: Assessment of Tolerability, Efficacy, and Impact on Erectile Function, Journal of Sexual Medicine (2015)
47. Assessment of Testicular Perfusion Prior to Sperm Extraction Predicts Success Rate and Decreases the Number of Required Biopsies in Patients With Non-Obstructive Azoospermia, International Urology and Nephrology (2015)
48. Comparison of the Efficacy of Two Brands of Triptorelin (Microrelin and Diphereline) in Reducing Prostate-Specific Antigen and Serum Testosterone in Prostate Cancer: A Double-Blinded Randomized Clinical Trial, Nephro-Urology Monthly (2015)
49. Contribution of Stone Size to Chronic Kidney Disease in Kidney Stone Formers, International Journal of Urology (2015)
50. Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences, Nephro-Urology Monthly (2015)
51. Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men, Nephro-Urology Monthly (2015)
52. Transition Zone Prostate-Specific Antigen Density Could Better Guide the Rebiopsy Strategy in Men With Prostate Inflammation at Initial Biopsy, Urology (2015)
53. Detection of Recurrent Bladder Cancer: Nmp22 Test or Urine Cytology?, Urology Journal (2012)